Related Experiment Video
Updated: Apr 20, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Diversity and disease pathogenesis in Mycobacterium tuberculosis
Digby F Warner1, Anastasia Koch1, Valerie Mizrahi1
1MRC/NHLS/UCT Molecular Mycobacteriology Research Unit, DST/NRF Centre of Excellence for Biomedical TB Research, Institute of Infectious Disease and Molecular Medicine and Department of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa.
Whole-genome sequencing reveals Mycobacterium tuberculosis evolution shaped by human persistence, host adaptation, and drug resistance. Understanding genotypic diversity is crucial for tuberculosis pathogenesis, vaccine efficacy, and treatment strategies.
Area of Science:
- Genomics
- Evolutionary biology
- Microbiology
Background:
- Tuberculosis (TB) remains a global health challenge.
- Mycobacterium tuberculosis (M. tuberculosis) is the causative agent of TB.
- Advances in whole-genome sequencing (WGS) provide unprecedented insights into M. tuberculosis evolution.
Purpose of the Study:
- To review the evolutionary forces shaping M. tuberculosis genotypes.
- To discuss the implications of genotypic diversity for TB pathogenesis, vaccine efficacy, and drug treatment.
Main Methods:
- Analysis of available whole-genome sequence (WGS) data for M. tuberculosis.
- Review of literature on evolutionary pressures and their impact on M. tuberculosis.
Main Results:
- M. tuberculosis evolution is driven by long-term human host persistence, lineage-specific adaptation, and drug exposure.
- Genotypic diversity influences disease pathogenesis and the emergence of drug resistance.
- Understanding these evolutionary dynamics is key to combating TB.
Conclusions:
- Genomic diversity in M. tuberculosis is a product of evolutionary pressures.
- Knowledge of M. tuberculosis genotypes is essential for developing effective TB control strategies, including vaccines and treatments.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Colonisation of Pathogens
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

